Drug intelligence / Profile preview

NFIB siRNA

Development stage
Unknown
Modality
Chemically Modified siRNA → Small Interfering RNA (siRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics, Conjugated siRNA → Small Interfering RNA (siRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics
01

Overview

NFIB siRNA is a research-grade small interfering RNA (siRNA) reagent designed to silence the expression of the Nuclear Factor I B-type (NFIB) gene via RNA interference (RNAi). NFIB is a transcription factor involved in various developmental processes and has been implicated in the progression of several cancers, including melanoma and estrogen receptor-negative breast cancer. By targeting the NFIB transcript for degradation, this siRNA reduces NFIB protein levels, allowing researchers to study its role in cell proliferation, apoptosis, and metastasis. It is primarily used as a laboratory tool and is available from various life science reagent suppliers such as Abbexa Ltd.

Other names
Nuclear Factor I B-type siRNANFI-B siRNANF1-B siRNANF-1-B siRNANF 1-B siRNATGGCA-binding protein siRNA
02

Targets

TLR7/8 (Toll-like receptor 7 and Toll-like receptor 8)NFIB (Nuclear factor I-B)

Beyond the preview

Go deeper on NFIB siRNA.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on NFIB siRNA.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call